Literature DB >> 1151402

Studies in man of phenytoin absorption and its implications.

F B Gibberd, M Webley.   

Abstract

The absorption of phenytoin was studied in man. It is concluded that phenytoin absorbed from the intestine is recirculated via the bile, so that blood levels do not accurately reflect absorption. Phenytoin is loosely bound to serum proteins and is found in red cells in concentrations similar to those in plasma. It is rapidly lost from the blood stream after intravenous administration, which is an important factor to be considered in the treatment of status epilepticus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1151402      PMCID: PMC491899          DOI: 10.1136/jnnp.38.3.219

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  Determination of diphenylhydantoin and phenobarbital in small amounts of serum.

Authors:  O SVENSMARK; P KRISTENSEN
Journal:  J Lab Clin Med       Date:  1963-03

2.  Studies on 5, 5'-diphenylhydantoin (dilantin) in animals and man.

Authors:  W A DILL; A J GLAZKO; A KAZENKO; L M WOLF
Journal:  J Pharmacol Exp Ther       Date:  1956-11       Impact factor: 4.030

3.  Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.

Authors:  P K Lunde; A Rane; S J Yaffe; L Lund; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1970 Nov-Dec       Impact factor: 6.875

4.  Plasma protein binding of tricyclic anti-depressants in man.

Authors:  O Borgå; D L Azarnoff; G P Forshell; F Sjöqvist
Journal:  Biochem Pharmacol       Date:  1969-09       Impact factor: 5.858

5.  Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography.

Authors:  J MacGee
Journal:  Anal Chem       Date:  1970-03       Impact factor: 6.986

6.  Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration.

Authors:  A J Glazko; T Chang; J Baukema; W A Dill; J R Goulet; R A Buchanan
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875

7.  Serum protein binding of thyroxine and diphenylhydantoin.

Authors:  R W Lightfoot; C L Christian
Journal:  J Clin Endocrinol Metab       Date:  1966-03       Impact factor: 5.958

8.  Plasma protein binding, plasma concentrations, and effects of diphenylhydantoin in man.

Authors:  L Lund; P K Lunde; A Rane; O Borga; F Sjöqvist
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

9.  Studies on the metabolism of diphenylhydantoin (Dilantin).

Authors:  E W LOESER
Journal:  Neurology       Date:  1961-05       Impact factor: 9.910

10.  Phenytoin tolerance tests.

Authors:  A J Handley
Journal:  Br Med J       Date:  1970-07-25
View more
  2 in total

1.  The influence of folic acid on the frequency of epileptic attacks.

Authors:  F B Gibberd; A Nicholls; M G Wright
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

Review 2.  The treatment of autism with low-dose phenytoin: a case report.

Authors:  Philip D Bird
Journal:  J Med Case Rep       Date:  2015-01-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.